LIVINGSTON, N.J., Feb. 15 /PRNewswire-FirstCall/ -- Milestone
Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in
advanced injection technologies, today announced that it will be exhibiting
at the upcoming Chicago Dental Society's 143rd Midwinter Meeting.
WHEN: Friday, February 22, 2008 - Sunday, February 24, 2008
WHERE: Booth #2206
McCormick Place Lakeside Center
2301 South Lake Shore Drive
WHO: Key Milestone officials, along with Henry Schein representatives,
will be available to discuss and demonstrate the STA(TM) System.
Learn first hand:
-- how Milestone is redefining the standard of care for the
delivery of local anesthesia in dentistry; and
-- how the STA System is promoting enhanced patient care and
improved practice efficiency for those dentists who have
adopted this novel technology since its unveiling at the 142nd
Midwinter Meeting last year.
Members of the press must register at the Press Booth for this event. For details on obtaining Press Credentials, please visit: http://www.cds.org/media/. To book a one-on-one meeting or demonstration, please contact John Morrison or Tiffany Korkis at 407-585-1080 or via email at email@example.com.
The Midwinter Meeting is among the top three dental meetings in the U.S. and one of the top 10 conventions in Chicago. Each year, more than 600 exhibiting companies participate in the meeting, creating one of the largest exhibits of dental products and manufacturers in North America. The theme for the 2008 Midwinter Meeting is "Charting Dental Success". The 2007 Midwinter Meeting drew more than 34,000 attendees and $48 million to the city of Chicago, including 7,793 dentists.
About the Chicago Dental Society
The Chicago Dental Society was organized in 1864 and incorporated in 1878. The objective of the Chicago Dental Society is to encourage the improvement of the health of the public, to promote the art and science of dentistry and to represent the interest of the members of the profession and the public that it serves. CDS memberships cover Cook, Lake and DuPage counties and includes approximately 4,100 members. For more information about the CDS, visit their Web site at http://www.cds.org/.
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(TM) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The Single Tooth Anesthesia (STA(TM)) computer-controlled local anesthesia delivery system which uses this technology provides dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at http://www.milesci.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the
timing and financial impact of the Milestone's ability to implement its
business plan, expected revenues and future success. These statements
involve a number of risks and uncertainties and are based on assumptions
involving judgments with respect to future economic, competitive and market
conditions and future business decisions, all of which are difficult or
impossible to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual results to
differ materially from those indicated by the forward-looking statements
are general economic conditions, failure to achieve expected revenue
growth, changes in our operating expenses, adverse patent rulings, FDA or
legal developments, competitive pressures, changes in customer and market
requirements and standards, and the risk factors detailed from time to time
in Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report on Form
10-KSB for the year ended December 31, 2006. The forward looking-statements
in this press release are based upon management's reasonable belief as of
the date hereof. Milestone undertakes no obligation to revise or update
publicly any forward-looking statements for any reason.
FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group, LLC
Dodi Handy, President and CEO, or Daniel Conway, Chief Strategy Officer
407-585-1080 or via email at firstname.lastname@example.org
|SOURCE Milestone Scientific Inc.|
Copyright©2008 PR Newswire.
All rights reserved